Frequency Therapeutics said yesterday that it priced its initial public offering at roughly $84 million.
The 6-million-share offering priced at $14 per share and includes a 30-day underwriters option on another 900,000 shares that’s worth $12.6 million, the Woburn, Mass.-based company said.
Get the full story at our sister site, Drug Delivery Business News.